Skip to content

Study of the mechanism of action of cortico-striato-thalamo-cortical neural circuits in patients with different phenotypes of obsessive-compulsive disorder

Study of the mechanism of action of cortico-striato-thalamo-cortical neural circuits in patients with different phenotypes of obsessive-compulsive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073157
Enrollment
Unknown
Registered
2023-07-03
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder

Interventions

Obsessive compulsive disorder:none
Healthy control group:none

Sponsors

the Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient group inclusion criteria: (1) Subjects were outpatients/inpatients (but subjects participating in the trial did not require hospitalization), and subjects met the DSM-5 diagnostic criteria for obsessive-compulsive disorder as determined by the MINI interview. (2) YBOCS-10 score = 16, or YBOCS-10 score of = 10 on the obsessive-compulsive thinking factor and = 6 on the obsessive-compulsive behavior factor. (3) Age 18-60 years old, regardless of gender. (4) Right-handedness. (5) junior high school education or above, ability to complete informed consent and complete cognitive tests. (6) During the follow-up period, subjects may take medication as prescribed by the outpatient or inpatient physician. Healthy control group inclusion criteria: (1) Subjects were recruited as healthy controls, and it was determined through the MINI interview that subjects did not meet any of the DSM-5 diagnostic criteria for mental disorders. (2) Age 18-60 years, regardless of gender; (3) Right-handedness; (4) Junior high school education or above, with the ability to complete informed consent and complete cognitive tests;

Exclusion criteria

Exclusion criteria: (1) Exclusion of patients with psychotic symptoms. (2) Exclusion of other serious mental illnesses (except generalized anxiety) that meet DSM-5 diagnostic criteria (via the MINI interview), including schizophrenia, schizoaffective disorder, schizophrenia-like disorder, delusional disorder or current psychotic symptoms, post-traumatic stress disorder (current or within the past year), or poor mental status. (3) With organic brain and serious physical illness (e.g., thyroid disease, lupus erythematosus, diabetes, pulmonary, hepatic, and renal impairment, infection, major trauma, etc.) excluding the presence of intracranial implants. (4) Those with serious suicidal ideation or suicide attempts (5) Patients on hormonal medication; (6) clinically significant sensory impairment that cannot be corrected (e.g., hearing impairment that prevents conversation) (7) Pregnant and lactating women (8) Other conditions that, in the opinion of the investigator, exist that make participation in this study inappropriate. Healthy control group exclusion criteria: (1) Patients who currently or previously meet any of the DSM-5 diagnostic criteria for mental disorders (2) Patients with organic brain and serious physical disease (e.g., thyroid disease, lupus erythematosus, diabetes mellitus, pulmonary, hepatic and renal impairment, infection, major trauma, etc.) excluding the presence of intracranial implants; (3) Patients being treated with hormonal drugs. (4) clinically significant sensory impairment that cannot be corrected (e.g., hearing impairment that prevents conversation) (5) Pregnant and lactating women; (6) Other conditions that, in the opinion of the investigator, exist that make participation in this study inappropriate.

Design outcomes

Primary

MeasureTime frame
Clinical self-assessment scales;EEG data;MRI;cognitive function;

Countries

China

Contacts

Public ContactYumeng Ju

the Second Xiangya Hospital of Central South University

mmh308232535@163.com+86 181 0073 1091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026